April 17, 2014 8:40 AM ET

Pharmaceuticals

Company Overview of Edusa Pharmaceuticals, Inc.

Company Overview

Edusa Pharmaceuticals, Inc., a biotechnology company, develops a compound to treat gastroesophageal reflux disease. It develops Pumosetrag, a 5-HT3 partial agonist to treat the symptoms of upper gastrointestinal dismotility. The Pumosetrag is used to treat gastroesophageal reflux disease and potentially gastroparesis symptoms in patients who continue to experience heartburn and regurgitation while on proton pump inhibitors or H2-antagonists. Edusa Pharmaceuticals, Inc. was formerly known as Dynogen Pharmaceuticals, Inc. As a result of acquisition of Dynogen Pharmaceuticals, Inc. by Care Capital, LLC, Dynogen Pharmaceuticals, Inc. name was changed in June 2009. Edusa Pharmaceuticals, Inc. w...

104 Carnegie Center

Suite 214

Princeton, NJ 08540

United States

Founded in 2002

Phone:

609-916-0232

Fax:

609-275-5610

Key Executives for Edusa Pharmaceuticals, Inc.

Chief Executive Officer
Age: 54
Co-Founder and Senior Director of Business Development
Chief Financial Officer and Director
Chief Operating Officer
Age: 53
Vice President of Finance & Administration and Treasurer
Age: 38
Compensation as of Fiscal Year 2013.

Similar Private Companies By Industry

Company Name Region
Omega Natural Science, Inc. United States
Epiomed Therapeutics, Inc. United States
Arbor Pharmaceuticals, LLC United States
Ascend Therapeutics, Inc. United States
Biotech Synergy, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Edusa Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.